Case Report: Personalized peptide-based immunization in an advanced-stage prostate cancer patient with bone metastasis
{{output}}
Neoantigens, which are recognized as non-self and trigger an immune response, are novel antigens generated by tumor cells. Here, we report a de novo metastatic hormone-sensitive prostate cancer (mHSPC) case, which benefited from our personalized peptide immuni... ...
